Online citations, reference lists, and bibliographies.
← Back to Search

Malignant Mesothelioma As An Oxidative Stress-induced Cancer: An Update.

S. H. Chew, S. Toyokuni
Published 2015 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Malignant mesothelioma (MM) is a relatively rare cancer that occurs almost exclusively following respiratory exposure to asbestos in humans. Its pathogenesis is closely associated with iron overload and oxidative stress in mesothelial cells. On fiber exposure, mesothelial cells accumulate fibers simultaneously with iron, which either performs physical scissor function or catalyzes free radical generation, leading to oxidative DNA damage such as strand breaks and base modifications, followed by activation of intracellular signaling pathways. Chrysotile, per se without iron, causes massive hemolysis and further adsorbs hemoglobin. Exposure to indigestible foreign materials also induces chronic inflammation, involving consistent generation of free radicals and subsequent activation of NALP3 inflammasomes in macrophages. All of these contribute to mesothelial carcinogenesis. Genomic alterations most frequently involve homozygous deletion of INK4A/4B, and other pathways such as Hippo and TGF-β pathways are also affected in MM. Recently, analyses of familial MM sorted out BAP1 as a novel responsible tumor suppressor gene, whose function is not fully elucidated. Five-year survival of mesothelioma is still ~8%, and this cancer is increasing worldwide. Connective tissue growth factor, a secretory protein creating a vicious cycle mediated by β-catenin, has been recognized as a hopeful target for therapy, especially in sarcomatoid subtype. Recent research outcomes related to microRNAs and cancer stem cells also offer additional novel targets for the treatment of MM. Iron reduction as chemoprevention of mesothelioma is helpful at least in an animal preclinical study. Integrated approaches to fiber-induced oxidative stress would be necessary to overcome this currently fatal disease.
This paper references
10.1016/j.ccm.2012.12.005
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
A. Haas (2013)
10.1097/PAS.0b013e318218985b
Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation
M. Shi (2011)
10.1016/S1470-2045(14)71109-X
Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes.
Y. Grosse (2014)
10.1002/IJC.2910620313
Treatment of wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes dna‐protein cross‐linking between thymine and tyrosine in their renal chromatin
S. Toyokuni (1995)
10.1016/j.bbrc.2012.02.054
Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
H. Yamazaki (2012)
10.1016/j.bbadis.2013.07.014
Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.
D. Valenti (2013)
10.1038/srep01144
Metamorphosis of mesothelial cells with active horizontal motility in tissue culture
H. Nagai (2013)
10.1016/0013-9351(71)90010-7
Experimental asbestos carcinogenesis
A. L. Reeves (1971)
10.1016/j.redox.2014.11.003
Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells
B. Cunniff (2014)
10.1046/j.1440-1843.2002.00404.x
Mesothelial cells: Their structure, function and role in serosal repair
S. Mutsaers (2002)
10.1002/(SICI)1096-9896(199910)189:2<258::AID-PATH410>3.0.CO;2-E
Induction of nuclear translocation of NF‐κB in epithelial cells by respirable mineral fibres
D. Brown (1999)
10.2217/bmm.11.18
Soluble markers for diagnosis of malignant pleural mesothelioma.
A. Cristaudo (2011)
10.1002/(SICI)1097-0274(199609)30:3<252::AID-AJIM2>3.0.CO;2-0
Chrysotile asbestos is the main cause of pleural mesothelioma.
A. Smith (1996)
10.1378/CHEST.94.5.1037
Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
T. Pettersson (1988)
10.1002/IJC.2910570122
DNA base modifications in renal chromatin of wistar rats treated with a renal carcinogen, ferric nitrilotriacetate
S. Toyokuni (1994)
10.1186/1476-069X-7-4
Translocation pathways for inhaled asbestos fibers
Giuseppe Miserocchi (2008)
10.1183/09031936.00207213
Multimodal management of malignant pleural mesothelioma: where are we today?
P. V. Van Schil (2014)
10.1006/TAAP.1998.8462
Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos.
A. Barchowsky (1998)
10.1016/J.JSS.2007.03.048
The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
J. Stewart (2007)
10.1002/PATH.1711450204
Mesothelial healing: Morphological and kinetic investigations
D. Whitaker (1985)
10.1002/cncr.10923
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions
P. Illei (2003)
10.1038/ng.912
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
10.1242/jcs.010389
The RASSF1A tumor suppressor
H. Donninger (2007)
10.1016/S0140-6736(82)90027-7
MESOTHELIOMA IN A BRAKE REPAIR WORKER
A. Langer (1982)
10.1016/j.ccr.2011.01.038
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.
Takatsugu Ishimoto (2011)
10.1002/path.4075
Iron overload signature in chrysotile‐induced malignant mesothelioma
L. Jiang (2012)
10.1155/2013/874212
Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
J. Creaney (2013)
10.1038/sj.onc.1208263
Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection
M. Suzuki (2005)
10.1124/PR.112.006171
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
F. Virgilio (2013)
10.1158/1940-6207.CAPR-13-0244
Deferasirox Induces Mesenchymal–Epithelial Transition in Crocidolite-Induced Mesothelial Carcinogenesis in Rats
H. Nagai (2013)
10.1200/JCO.2011.41.2965
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.
T. Wiesner (2012)
10.1183/09031936.00226111
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma
I. Pantazopoulos (2012)
10.1093/annhyg/meq076
Epidemiology of malignant mesothelioma--an outline.
J. C. Mcdonald (2010)
10.1158/1078-0432.CCR-06-2144
Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment
B. Grigoriu (2007)
10.3389/fphys.2015.00093
Oxidative stress-mediated HMGB1 biology
Y. Yu (2015)
10.1200/JCO.2011.39.6671
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.
Kevin Hollevoet (2012)
10.1158/0008-5472.CAN-11-3481
Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.
S. Jube (2012)
10.1093/carcin/bgn200
YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation.
T. Yokoyama (2008)
10.7314/APJCP.2013.14.6.3625
Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells.
Myung-Chul Kim (2013)
10.1016/0013-9351(71)90038-7
Hemolysis by asbestos.
J. Harington (1971)
Mesothelial regeneration in the rat and effect of urokinase.
S. Teranishi (1977)
10.1038/labinvest.2009.140
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma
Q. Hu (2010)
10.1111/j.1349-7006.2011.02087.x
Asbestos surface provides a niche for oxidative modification
H. Nagai (2011)
10.2471/BLT.11.086678
Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.
V. Delgermaa (2011)
10.1111/j.1349-7006.2006.00386.x
Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including JUN amplification on 1p32
T. Taniguchi (2007)
10.1093/CARCIN/18.4.825
Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos.
H. Fung (1997)
10.1378/chest.08-2665
Malignant pleural mesothelioma: an update on biomarkers and treatment.
M. Ray (2009)
10.1006/EXMP.1999.2268
Role of Transcription Factor NF-κB in Asbestos-Induced TNFα Response from Macrophages☆
N. Cheng (1999)
10.1186/1471-2407-13-205
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
C. Tabata (2012)
10.3892/IJO.25.1.173
Interleukin-1β and tumour necrosis factor-α promote the transformation of human immortalised mesothelial cells by erionite
Y. Wang (2004)
10.1002/(SICI)1096-9896(200001)190:1<86::AID-PATH493>3.0.CO;2-G
Mesothelial regeneration is not dependent on subserosal cells
S. Mutsaers (2000)
10.1371/journal.pone.0039404
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
Kheng Newick (2012)
10.1016/J.LUNGCAN.2005.10.016
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations.
A. Destro (2006)
10.1074/jbc.M110.100354
Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma*
S. Ivanov (2010)
10.1016/0891-5849(92)90117-Y
The role of free radicals in asbestos-induced diseases.
D. Kamp (1992)
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
J. Cheng (1994)
10.3346/JKMS.2007.22.6.943
Mechanisms of Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells During Peritoneal Dialysis
H. Lee (2007)
10.1165/AJRCMB/9.2.186
Induction of metaphase and anaphase/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro.
M. Yegles (1993)
Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages.
L. Goodglick (1986)
10.1097/JTO.0b013e31820db125
MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
Veronica Balatti (2011)
10.1016/s0140-6736(63)92866-6
THE FIRST FIFTY YEARS.
Dall Jl (1963)
10.1016/j.lungcan.2008.02.012
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.
K. Iwahori (2008)
10.1002/jcp.24232
Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells
B. Cunniff (2013)
10.1378/CHEST.07-0013
Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.
J. Creaney (2007)
10.1038/ncomms4315
A Functional Interaction between Hippo-YAP Signaling and FoxO1 Mediates the Oxidative Stress Response
Dan Shao (2014)
10.1152/ajplung.1999.277.4.L684
Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosis.
C. Zanella (1999)
10.1038/214522a0
Haemolytic Activity of Asbestos and other Mineral Dusts
G. Macnab (1967)
10.1093/MUTAGE/15.3.239
DNA breakage in asbestos-treated normal and transformed (TSV40) rat pleural mesothelial cells.
V. Levresse (2000)
10.18999/NAGJMS.71.1-2.1
[Mechanisms of asbestos-induced carcinogenesis].
S. Toyokuni (2011)
10.1016/0162-0134(92)84069-Y
Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron.
S. Toyokuni (1992)
10.1158/0008-5472.CAN-05-2312
A mouse model recapitulating molecular features of human mesothelioma.
D. Altomare (2005)
10.1038/BJC.1973.134
Mesotheliomata in Rats after Inoculation with Asbestos and Other Materials
J. Wagner (1973)
10.1136/bmjopen-2013-004145
Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis
Ai Cui (2014)
10.1016/j.lungcan.2011.02.007
Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?
J. Creaney (2011)
10.1002/PATH.1711510309
Role of macrophages in mesothelial healing
Z. Fotev (1987)
10.1073/PNAS.92.24.10854
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
A. Bianchi (1995)
10.1164/rccm.200907-1020OC
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.
K. Hollevoet (2010)
10.1111/j.1349-7006.2008.00934.x
Characteristics and modifying factors of asbestos‐induced oxidative DNA damage
L. Jiang (2008)
10.1056/NEJMoa1115050
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.
H. Pass (2012)
10.1093/CARCIN/14.2.223
DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis.
S. Toyokuni (1993)
10.1136/oem.17.4.260
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
J. Wagner (1960)
10.1126/SCIENCE.2153315
Asbestos: scientific developments and implications for public policy.
B. Mossman (1990)
10.1016/j.ajpath.2013.07.029
Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.
Fang Wei Qi (2013)
10.3892/MCO.2013.175
Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.
K. Fukuoka (2013)
10.1016/j.ajpath.2010.10.039
Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.
D. Jean (2011)
10.1073/pnas.1110013108
Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis
H. Nagai (2011)
10.1371/journal.pone.0018232
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
L. Santarelli (2011)
10.1097/MCG.0b013e31824e901b
Serum Thioredoxin-1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma
C. Tabata (2013)
10.1089/ars.2013.5215
MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function.
M. Tomasetti (2014)
10.1038/modpathol.2010.134
Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium
A. Sato (2010)
10.1152/ajplung.1997.273.5.L1029
Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2.
L. A. Jiménez (1997)
10.1289/EHP.8351331
Effects of crocidolite and chrysotile asbestos on cellular uptake and metabolism of benzo(a)pyrene in hamster tracheal epithelial cells.
B. Mossman (1983)
10.1093/CARCIN/BGM090
Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis.
W. Aung (2007)
10.1016/0891-5849(95)02184-1
Association between 8-hydroxy-2'-deoxyguanosine formation and DNA strand breaks mediated by copper and iron.
S. Toyokuni (1996)
Cigarette smoke increases the penetration of asbestos fibers into airway walls.
D. McFadden (1986)
10.1158/1940-6207.CAPR-13-0259
Curcumin: A Double Hit on Malignant Mesothelioma
Jill M. Miller (2014)
10.2353/AJPATH.2006.051280
Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis.
S. Akatsuka (2006)
10.1371/journal.pone.0030221
Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma – A Pilot Study
D. Weber (2012)
10.1093/dnares/dsu023
Genome-wide Profiling of 8-Oxoguanine Reveals Its Association with Spatial Positioning in Nucleus
M. Yoshihara (2014)
10.1097/JTO.0b013e318180477b
Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma
J. Creaney (2008)
10.1002/CM.20151
Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts.
R. A. MacCorkle (2006)
10.2353/jmoldx.2010.090169
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.
H. Benjamin (2010)
Asbestos fibre content of lungs with mesotheliomas in Osaka, Japan: a preliminary report.
K. Morinaga (1989)
10.3892/IJO_00000692
Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed.
L. Cortes-Dericks (2010)
10.1016/0891-5849(95)02111-6
Iron-induced carcinogenesis: the role of redox regulation.
S. Toyokuni (1996)
10.1093/BRAIN/AWM249
Magic but treatable? Tumours due to loss of merlin.
C. O. Hanemann (2008)
10.1038/bjc.2011.104
Markers for the non-invasive diagnosis of mesothelioma: a systematic review
S. van der Bij (2011)
10.1073/pnas.0604008103
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
H. Yang (2006)
10.1371/journal.pone.0114483
Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
D. Weber (2014)
Non-asbestos related diffuse malignant mesothelioma.
M. Huncharek (2002)
10.1002/ijc.25285
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
G. V. Gee (2010)
10.18999/NAGJMS.76.1-2.149
RAT MODEL DEMONSTRATES A HIGH RISK OF TREMOLITE BUT A LOW RISK OF ANTHOPHYLLITE FOR MESOTHELIAL CARCINOGENESIS
Dilinuer Aierken (2014)
10.1093/CARCIN/17.9.2013
Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis.
C. Jensen (1996)
10.1126/science.1156995
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
10.1371/journal.pone.0043403
Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer
S. Akatsuka (2012)
10.1164/AJRCCM.153.1.8542156
Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study.
C. Boutin (1996)
10.1186/1743-8977-7-5
Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma
K. Donaldson (2009)
10.1111/j.1349-7006.2008.01001.x
Role of iron in carcinogenesis: Cancer as a ferrotoxic disease
S. Toyokuni (2009)
10.1093/carcin/bgr127
Pleural mesothelioma side populations have a precursor phenotype.
C. Frei (2011)
10.2131/JTS.33.105
Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube.
A. Takagi (2008)
Regeneration of parietal and visceral peritoneum: an electron microscopical study.
Raftery At (1973)
10.1179/1351000213Y.0000000064
Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy
J. Kovářová (2014)
10.1089/ars.2010.3356
High-mobility group box 1, oxidative stress, and disease.
D. Tang (2011)
10.1016/j.annepidem.2011.05.010
Mesothelioma from chrysotile asbestos: update.
M. Kanarek (2011)
10.1136/oem.45.5.305
Correlation between fibre content of the lung and disease in east London asbestos factory workers.
J. Wagner (1988)
10.3892/ijo.2013.2092
Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells
T. Tatsuta (2013)
10.1158/1078-0432.CCR-08-1579
Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
F. Vandermeers (2009)
Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
C. Zanella (1996)
10.1136/thoraxjnl-2014-205205
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
J. Creaney (2014)
10.1093/ANNHYG/26.3.417
Mineral fibre content of lung in mesothelial tumours in North America.
A. Mcdonald (1982)
10.1016/j.molcel.2010.09.027
MicroRNA functions in stress responses.
A. Leung (2010)
10.1158/0008-5472.CAN-04-4567
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
R. Jagadeeswaran (2006)
10.1073/pnas.1006542107
Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation
H. Yang (2010)
10.1073/PNAS.90.8.3299
Persistent induction of c-fos and c-jun expression by asbestos.
N. H. Heintz (1993)
10.3978/j.issn.2225-319X.2012.11.04
Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M. Robinson (2012)
10.3109/10715762.2011.564170
Iron as a target of chemoprevention for longevity in humans
S. Toyokuni (2011)
10.1289/ehp.9425
New Insight into Intrachromosomal Deletions Induced by Chrysotile in the gpt delta Transgenic Mutation Assay
A. Xu (2007)
10.1038/cdd.2013.125
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
E. Mogilyansky (2013)
10.1016/j.clinbiochem.2009.03.007
Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.
B. Grigoriu (2009)
10.1016/S0046-8177(82)80227-X
Fiber counting and analysis in the diagnosis of asbestos-related disease.
A. Churg (1982)
10.1158/0008-5472.CAN-10-2164
LATS2 is a tumor suppressor gene of malignant mesothelioma.
H. Murakami (2011)
10.1093/CARCIN/13.11.2035
Fiber-induced hydroxyl radical formation: correlation with mesothelioma induction in rats and humans.
K. Maples (1992)
10.1371/journal.pone.0052825
Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis
S. Varghese (2012)
10.1172/JCI118246
Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5.
A. Boylan (1995)
10.1289/ehp.95103268
Mitotic disturbances and micronucleus induction in Syrian hamster embryo fibroblast cells caused by asbestos fibers.
E. Dopp (1995)
10.1093/carcin/bgt267
Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
S. H. Chew (2014)
10.1002/gcc.20669
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis
Mohamed Guled (2009)
10.1038/nrm2831
BRCA1 and its toolbox for the maintenance of genome integrity
Michael S. Y. Huen (2010)
Codeletion of p15 and p16 in primary malignant mesothelioma.
S. Xio (1995)
Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers.
J. Pache (1998)
Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos.
T. Quinlan (1995)
10.1371/journal.pone.0046091
Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
R. Ostroff (2012)
10.1165/rcmb.2009-0060OC
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Sara Busacca (2010)
10.1016/j.addr.2013.05.011
Genotoxicity and carcinogenicity risk of carbon nanotubes.
S. Toyokuni (2013)
10.1186/1743-8977-11-24
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
Joyce K. Thompson (2014)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1093/CARCIN/16.2.319
The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks.
J. Hardy (1995)
10.1084/jem.20111653
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
M. Fujii (2012)
10.1073/pnas.1203326109
BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation
S. Stecklein (2012)
10.3164/jcbn.12-39
Distinct affinity of nuclear proteins to the surface of chrysotile and crocidolite
Yurika Kubo (2012)
10.1093/jnci/djn209
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
L. Zacharski (2008)
10.1038/labinvest.2015.28
Receptor role of the annexin A2 in the mesothelial endocytosis of crocidolite fibers
K. Yamashita (2015)
10.1093/CARCIN/15.6.1251
Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro.
H. Dong (1994)
10.1016/j.soc.2012.12.004
Multimodality treatment of pleural mesothelioma.
David D. Shersher (2013)
10.1002/1097-0142(19870615)59:12<2104::AID-CNCR2820591224>3.0.CO;2-I
Serum hyaluronate in malignant pleural mesothelioma
T. Frebourg (1987)
10.1165/AJRCMB.23.3.4094
Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells.
W. Liu (2000)
10.1111/cas.12185
CD146 and insulin‐like growth factor 2 mRNA‐binding protein 3 predict prognosis of asbestos‐induced rat mesothelioma
Y. Okazaki (2013)
10.1016/0169-5002(95)90162-0
Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
Y. Sekido (1995)
10.3164/jcbn.10-38R
Genome-Scale Approaches to Investigate Oxidative DNA Damage
S. Akatsuka (2010)
10.1016/J.MRGENTOX.2003.12.006
Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor.
I. Poser (2004)
10.3389/fphar.2014.00200
Iron and thiols as two major players in carcinogenesis: friends or foes?
S. Toyokuni (2014)
10.1038/ng.855
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew J Bott (2011)
10.1179/1351000213Y.0000000075
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis
S. Toyokuni (2014)
10.1002/path.4377
Connective tissue growth factor and β‐catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma
L. Jiang (2014)



This paper is referenced by
10.7176/jstr/5-6-02
Asbestos Exposure and Lung Carcinogenesis: Mechanism and Applications
P. E. Tokgun (2019)
PROGRESS AND CHALLENGES IN MESOTHELIOMA: FROM BENCH TO BEDSIDE Authors
K. Blyth (2017)
10.1007/978-3-319-53560-9_9
Gene Signature of Malignant Pleural Mesothelioma
A. D. Rienzo (2017)
10.1038/s41598-017-04472-4
No cancer predisposition or increased spontaneous mutation frequencies in NEIL DNA glycosylases-deficient mice
V. Rolseth (2017)
10.1111/cas.13460
Phlebotomy as a preventive measure for crocidolite‐induced mesothelioma in male rats
Y. Ohara (2018)
10.1080/10715762.2020.1743285
Mth1 deficiency provides longer survival upon intraperitoneal crocidolite injection in female mice
S. Funahashi (2020)
10.1016/j.freeradbiomed.2017.04.368
Non‐thermal plasma induces a stress response in mesothelioma cells resulting in increased endocytosis, lysosome biogenesis and autophagy
L. Shi (2017)
Peroxide dependent effects in human airway epithelial cells exposed to oxidant air pollutants
Phillip A Wages (2016)
10.1016/j.freeradbiomed.2018.10.401
Iron addiction with ferroptosis‐resistance in asbestos‐induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention
S. Toyokuni (2019)
10.1007/978-981-10-0351-6_1
Suppressive Effects of Asbestos Exposure on the Human Immune Surveillance System
Y. Nishimura (2017)
10.1186/s12989-016-0158-0
Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells
F. Huaux (2016)
10.3892/or.2020.7669
Connective tissue growth factor produced by cancer-associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma
Y. Ohara (2020)
Chapter 12 Biomarkers of Response to Asbestos Exposure
Blair ()
10.4067/s0717-95022020000501217
Induction of Brain Injury and Depression in Rats by Chronic Unpredictable Stress Associated with the Augmentation of Nitrosative Stress and Apoptosis
I. Bin-Jaliah (2020)
10.3892/or.2019.7401
Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next-generation sequencing
H. Wu (2019)
10.1080/10715762.2018.1514604
Global overexpression of divalent metal transporter 1 delays crocidolite-induced mesothelial carcinogenesis in male mice
S. Funahashi (2018)
10.18632/oncotarget.19872
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function
Lucie Hébert (2017)
10.1007/S10163-019-00870-0
Virtuous cycle of destruction and total recycling of pure asbestos and asbestos-containing waste
G. Talbi (2019)
10.3390/ht7030020
Genomics and Epigenetics of Malignant Mesothelioma
Adam P Sage (2018)
10.1007/978-3-319-53560-9_12
Biomarkers of Response to Asbestos Exposure
C. Mesaros (2017)
10.1096/fj.201900396RR
Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer
F. Mroueh (2019)
10.3892/or.2018.6481
Aberrant expression of FoxP3 in a human T cell line possessing regulatory T cell‑like function and exposed continuously to asbestos fibers.
M. Maeda (2018)
10.2478/JOMB-2019-0025
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases.
A. Franko (2020)
10.3390/ijms18040867
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction
Yusuke Kanda (2017)
10.1038/s41416-019-0661-9
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
L. Urso (2019)
10.2478/raon-2020-0057
The Influence of Genetic Variability in IL1B and MIR146A on the Risk of Pleural Plaques and Malignant Mesothelioma
Petra Piber (2020)
10.1080/15287394.2015.1123452
Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study
S. Crovella (2016)
10.1007/978-3-030-16884-1_5
Microenvironment and Immunology of the Human Pleural Malignant Mesothelioma
Elisabeth Digifico (2019)
10.1016/j.redox.2019.101297
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
Zili Li (2019)
10.1111/pin.12598
Fenton reaction‐induced renal carcinogenesis in Mutyh‐deficient mice exhibits less chromosomal aberrations than the rat model
G. H. Li (2017)
10.1155/2016/7530853
Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2
Yuan Luo (2016)
10.1007/978-3-030-16884-1_2
Asbestos and the Pathophysiology of Mesothelioma
N. Zandwijk (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar